Collplant Biotechnologies

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$73
$60
$77
$179
Gross Profit
-243
-348
-415
-236
EBITDA
-2,905
-2,934
-3,260
-2,949
EBIT
-3,115
-3,150
-3,483
-3,178
Net Income
-3,097
-3,207
-3,483
-3,347
Net Change In Cash
73
60
77
179
Free Cash Flow
-3,055
-3,226
-2,877
-2,443
Cash
4,262
5,950
8,547
11,707
Basic Shares
13,747
12,803
12,722
11,840

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,371
$515
$10,959
$299
Gross Profit
624
-2,148
7,866
-1,177
EBITDA
-10,571
-15,554
-5,907
-15,815
EBIT
-11,483
-16,592
-7,009
-16,891
Net Income
-11,489
-16,609
-7,019
-16,925
Net Change In Cash
2,371
515
10,959
299
Free Cash Flow
-9,447
-14,576
-3,716
-14,972
Cash
5,950
11,909
26,674
29,653
Basic Shares
12,203
11,454
11,389
11,033

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.25
2025-09-30
-$0.25
2025-06-30
-$0.28